Cancer: Polymorphisms in detoxification genes increase HMTC risk and match tumour phenotype

Nature Reviews Endocrinology

Volumn 9, Issue 3, 2013, Pages 128-

  Koch, Linda ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; CONTROLLED STUDY; DETOXIFICATION; GENE; GENETIC POLYMORPHISM; GENOTYPE; GSTP1 GENE; HEREDITARY MEDULLARY THYROID CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; NAT2 GENE; NOTE; PHENOTYPE; PRIORITY JOURNAL; QUALITY OF LIFE; THYROID MEDULLARY CARCINOMA; TP53 GENE;

EID: 84875543947     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2013.6     Document Type: Note

References (1)

1. Brandt, F. et al. Graves disease and toxic nodular goiter are both associated with increased mortality but differ with respect to the cause of death. A Danish population-based register study. Thyroid doi:10.1089/thy.2012. 0500